Drug Topics - October 13, 2008 - (Page 70) 70 DRUG TOPICS Oct. 13, 2008 www.drugtopics.com Technology Rhode Island physicians connect to SureScripts-RxHub Louise Gagnon T he need to increase efficiencies, cut costs and decrease the potential for drug errors has motivated the nation’s largest health-plan-owned manager of pharmacy benefits to provide SureScripts-RxHub connectivity to health professionals in Rhode Island. The connectivity will allow physicians access both to a formulary and, with patients’ consent, to patient Marion Hague, assistant vice president of ancillary contracting for Blue Cross and Blue Shield medical information to determine at the point of care whether the patient’s health plan will cover the cost of medications, said Marion Hague, assistant vice president of ancillary contracting for Blue Cross and Blue Shield of Rhode Island (BCBSRI), which covers more than 680,000 members. “We want to make sure our physician community is sharing information in the most efficient way possible,” Hague said. “One of the things we had heard anecdotally is that they wanted easier access to our formulary. We wanted to make sure that we weren’t creating any barriers to e-prescribing, and this seemed to be a good way of eliminating any barriers.” Hague noted BCBSR I and WellPoint R x have experienced a healthy partnership on other initiatives, such as the OTC [Over-theCounter] Options Program, which enables prescribers to access the drug formulary, review the claims history, and see patients’ existing medication regimens to determine whether an over-the-counter drug is an appropriate choice for the patient. “When the pilot projects work well and the collaboration is successful, we are able to move onto another level,” Hague said. “There was a good effort on OTC Options Programs, and now we have moved onto something more ambitious, the SureScripts-Rx Hub connectivity. Everyone at the Rhode Island Quality Institute agreed that legible prescriptions and eliminating medication safety errors would be the way to go.” The Rhode Island Quality Institute, an organization that involves senior health-care professionals such as hospital administrators, physicians, consumers, universit y educators, and leaders in public health, business and insurance, examines through various strategies the potential for improving health care. The uptake of electronic prescribing requires facilitating prescriber access to information, Hague said. “Our own physicians told us that a lack of access to the drug formulary represents a barrier to e-prescribing. Having decision support tools further permits e-prescribing.” The new connectivity will see physicians equipped with handheld devices that allow them to contact a patient, obtain consent to review the medication history, determine whether the patient is eligible for a drug, and access the formulary to obtain a less expensive, generic, or alternative drug with a lower co-payment. BCBSR I is tracking the use of electronic prescribing and will survey physicians to evaluate whether they are electronically prescribing and how comfortable they are with the practice, Hague said. “It represents a change in their workf low and a financial investment on the part of physicians,” Hague said, noting that physicians need to purchase software packages that facilitate electronic prescribing. BCBSRI is also providing support for the development of electronic health records and offering financial incentive programs aimed at physicians to encourage prescription of generic drugs, Hague said. Kristi Meyer, vice president of marketing and product development for Well Point NextRx, said that it is a common objective for WellPoint NextRx http://www.drugtopics.com
Table of Contents Feed for the Digital Edition of Drug Topics - October 13, 2008 Drug Topics - October 13, 2008 Contents Latebreakers Letters Kansas Pharmacists Partner with Law Enforcement to Fight Meth Use Pharmacy Board to Oversee Med Distribution at West Virginia Free Clinics Rx Care JPat Large Celebrating Community Special Report Self-Care Government and Law Newer Treatment Option for Type 2 Diabetes New Products Advertisers Index Technology Classified Viewpoint:Pharmacists Must Change our Ways Drug Topics - October 13, 2008 Drug Topics - October 13, 2008 - (Page introA) Drug Topics - October 13, 2008 - (Page introB) Drug Topics - October 13, 2008 - Drug Topics - October 13, 2008 (Page Cover1) Drug Topics - October 13, 2008 - Drug Topics - October 13, 2008 (Page Cover2) Drug Topics - October 13, 2008 - Drug Topics - October 13, 2008 (Page 1) Drug Topics - October 13, 2008 - Contents (Page 2) Drug Topics - October 13, 2008 - Contents (Page 3) Drug Topics - October 13, 2008 - Contents (Page 4) Drug Topics - October 13, 2008 - Contents (Page 5) Drug Topics - October 13, 2008 - Contents (Page 6) Drug Topics - October 13, 2008 - Contents (Page 7) Drug Topics - October 13, 2008 - Latebreakers (Page 8) Drug Topics - October 13, 2008 - Latebreakers (Page 9) Drug Topics - October 13, 2008 - Latebreakers (Page 10) Drug Topics - October 13, 2008 - Latebreakers (Page 11) Drug Topics - October 13, 2008 - Latebreakers (Page 12) Drug Topics - October 13, 2008 - Latebreakers (Page HSE1) Drug Topics - October 13, 2008 - Latebreakers (Page HSE2) Drug Topics - October 13, 2008 - Latebreakers (Page HSE3) Drug Topics - October 13, 2008 - Latebreakers (Page HSE4) Drug Topics - October 13, 2008 - Latebreakers (Page HSE5) Drug Topics - October 13, 2008 - Latebreakers (Page HSE6) Drug Topics - October 13, 2008 - Latebreakers (Page HSE7) Drug Topics - October 13, 2008 - Latebreakers (Page HSE8) Drug Topics - October 13, 2008 - Latebreakers (Page HSE9) Drug Topics - October 13, 2008 - Latebreakers (Page HSE10) Drug Topics - October 13, 2008 - Latebreakers (Page HSE11) Drug Topics - October 13, 2008 - Latebreakers (Page HSE12) Drug Topics - October 13, 2008 - Latebreakers (Page HSE13) Drug Topics - October 13, 2008 - Latebreakers (Page HSE14) Drug Topics - October 13, 2008 - Latebreakers (Page HSE15) Drug Topics - October 13, 2008 - Latebreakers (Page HSE16) Drug Topics - October 13, 2008 - Latebreakers (Page HSE17) Drug Topics - October 13, 2008 - Latebreakers (Page HSE18) Drug Topics - October 13, 2008 - Latebreakers (Page HSE19) Drug Topics - October 13, 2008 - Latebreakers (Page 13) Drug Topics - October 13, 2008 - Letters (Page 14) Drug Topics - October 13, 2008 - Letters (Page 15) Drug Topics - October 13, 2008 - Letters (Page 16) Drug Topics - October 13, 2008 - Letters (Page 1s) Drug Topics - October 13, 2008 - Letters (Page 2s) Drug Topics - October 13, 2008 - Letters (Page 3s) Drug Topics - October 13, 2008 - Letters (Page 4s) Drug Topics - October 13, 2008 - Letters (Page 5s) Drug Topics - October 13, 2008 - Letters (Page 6s) Drug Topics - October 13, 2008 - Letters (Page 7s) Drug Topics - October 13, 2008 - Letters (Page 8s) Drug Topics - October 13, 2008 - Letters (Page 9s) Drug Topics - October 13, 2008 - Letters (Page 10s) Drug Topics - October 13, 2008 - Letters (Page 11s) Drug Topics - October 13, 2008 - Letters (Page 12s) Drug Topics - October 13, 2008 - Kansas Pharmacists Partner with Law Enforcement to Fight Meth Use (Page 17) Drug Topics - October 13, 2008 - Pharmacy Board to Oversee Med Distribution at West Virginia Free Clinics (Page 18) Drug Topics - October 13, 2008 - Pharmacy Board to Oversee Med Distribution at West Virginia Free Clinics (Page 19) Drug Topics - October 13, 2008 - Pharmacy Board to Oversee Med Distribution at West Virginia Free Clinics (Page 19a) Drug Topics - October 13, 2008 - Pharmacy Board to Oversee Med Distribution at West Virginia Free Clinics (Page 20) Drug Topics - October 13, 2008 - Rx Care (Page 21) Drug Topics - October 13, 2008 - Rx Care (Page 22) Drug Topics - October 13, 2008 - JPat Large (Page 23) Drug Topics - October 13, 2008 - Celebrating Community (Page 24) Drug Topics - October 13, 2008 - Celebrating Community (Page 25) Drug Topics - October 13, 2008 - Celebrating Community (Page 26) Drug Topics - October 13, 2008 - Celebrating Community (Page 27) Drug Topics - October 13, 2008 - Celebrating Community (Page 28) Drug Topics - October 13, 2008 - Celebrating Community (Page 29) Drug Topics - October 13, 2008 - Celebrating Community (Page 30) Drug Topics - October 13, 2008 - Celebrating Community (Page 31) Drug Topics - October 13, 2008 - Special Report (Page 32) Drug Topics - October 13, 2008 - Special Report (Page 33) Drug Topics - October 13, 2008 - Special Report (Page 34) Drug Topics - October 13, 2008 - Special Report (Page 35) Drug Topics - October 13, 2008 - Special Report (Page 36) Drug Topics - October 13, 2008 - Special Report (Page 37) Drug Topics - October 13, 2008 - Special Report (Page 38) Drug Topics - October 13, 2008 - Special Report (Page 39) Drug Topics - October 13, 2008 - Special Report (Page 40) Drug Topics - October 13, 2008 - Special Report (Page 41) Drug Topics - October 13, 2008 - Special Report (Page 42) Drug Topics - October 13, 2008 - Special Report (Page 43) Drug Topics - October 13, 2008 - Special Report (Page 44) Drug Topics - October 13, 2008 - Special Report (Page 45) Drug Topics - October 13, 2008 - Self-Care (Page 46) Drug Topics - October 13, 2008 - Self-Care (Page 47) Drug Topics - October 13, 2008 - Self-Care (Page 48) Drug Topics - October 13, 2008 - Self-Care (Page CP1) Drug Topics - October 13, 2008 - Self-Care (Page CP2) Drug Topics - October 13, 2008 - Self-Care (Page CP3) Drug Topics - October 13, 2008 - Self-Care (Page CP4) Drug Topics - October 13, 2008 - Self-Care (Page CP5) Drug Topics - October 13, 2008 - Self-Care (Page CP6) Drug Topics - October 13, 2008 - Self-Care (Page 49) Drug Topics - October 13, 2008 - Self-Care (Page 50) Drug Topics - October 13, 2008 - Self-Care (Page 51) Drug Topics - October 13, 2008 - Government and Law (Page 52) Drug Topics - October 13, 2008 - Government and Law (Page 53) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 54) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 55) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 56) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 57) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 58) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 59) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 60) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 61) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 62) Drug Topics - October 13, 2008 - Newer Treatment Option for Type 2 Diabetes (Page 63) Drug Topics - October 13, 2008 - Advertisers Index (Page 64) Drug Topics - October 13, 2008 - Advertisers Index (Page 65) Drug Topics - October 13, 2008 - Advertisers Index (Page 65a) Drug Topics - October 13, 2008 - Advertisers Index (Page 65b) Drug Topics - October 13, 2008 - Advertisers Index (Page 66) Drug Topics - October 13, 2008 - Advertisers Index (Page 67) Drug Topics - October 13, 2008 - Advertisers Index (Page 68) Drug Topics - October 13, 2008 - Advertisers Index (Page 69) Drug Topics - October 13, 2008 - Technology (Page 70) Drug Topics - October 13, 2008 - Technology (Page 71) Drug Topics - October 13, 2008 - Classified (Page 72) Drug Topics - October 13, 2008 - Classified (Page 73) Drug Topics - October 13, 2008 - Classified (Page 74) Drug Topics - October 13, 2008 - Classified (Page 75) Drug Topics - October 13, 2008 - Viewpoint:Pharmacists Must Change our Ways (Page 76) Drug Topics - October 13, 2008 - Drug Topics - October 13, 2008 (Page Cover1) Drug Topics - October 13, 2008 - Drug Topics - October 13, 2008 (Page Cover2)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.